Status:
TERMINATED
Heat-not-burn Tobacco Product to Aid in Switching From Combustible to Noncombustible Nicotine (IQOS)
Lead Sponsor:
University of Pittsburgh
Conditions:
Smoking Behaviors
Eligibility:
All Genders
21-77 years
Phase:
NA
Brief Summary
A novel heat-not-burn tobacco product (IQOS) will be provided to smokers, compared against a (cigarette) smoking as usual period in counter-balanced order in a cross-over design. This study will exami...
Detailed Description
The current within-subjects crossover study aims to directly compare initial efficacy of IQOS vs (cigarette) smoking as usual on switching from tobacco cigarettes during two-week "practice" periods in...
Eligibility Criteria
Inclusion
- Male or female, ages 21-77
- Current smoker with ≥5 cigarettes per day for ≥1 year history of smoking
- Screening CO ≥8 ppm
- Not currently interested in quitting smoking
- Willing to briefly switch from combustible to noncombustible nicotine
- Have reliable daily access to a smartphone or tablet compatible with the iCO Smokerlyzer app:
- Android 8 or higher, iOS 8 or higher
- Bluetooth-enabled device
Exclusion
- Current use of smoking cessation medications such as varenicline or bupropion
- Major chronic medical problems, including cardiovascular disease, diabetes
- Pregnancy (a urine pregnancy test will be administered at screening for all women of child bearing potential).
Key Trial Info
Start Date :
June 23 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2022
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT04861428
Start Date
June 23 2021
End Date
April 30 2022
Last Update
April 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UPMC Hillman Cancer Center
Pittsburgh, Pennsylvania, United States, 15232